Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations
Clinical trial NCT03877510 · COMPLETED
Trial details
- NCT number
- NCT03877510
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2022-03-21
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.